MYELOPROLIFERATIVE NEOPLASM

Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 26 Not yet recruiting 1 Not yet finished but already full! 12 Completed 4 Terminated 1

New drug tested to stop blood Cancer's return after risky transplant

Disease control Terminated

This early-stage trial tested whether a drug called fedratinib could safely prevent cancer from returning in patients with certain blood cancers (myeloproliferative neoplasms) after they received a stem cell transplant. The study aimed to find the safest effective dose and see if…

Matched conditions: MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

MYELOPROLIFERATIVE NEOPLASM

Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear

New drug tested to stop blood Cancer's return after risky transplant